Biotricity is trading 11.11% down at $0.08, despite a broader risk-on session that does not explain the move.
- No company-specific announcement dated September 21, 2026, or September 20, 2026, was identified in available company news listings.
- The latest listed releases are from June and May 2026.
- The decline may reflect thin-liquidity trading or selling pressure.